MARKET

LTRN

LTRN

Lantern Pharma Inc
NASDAQ
2.960
-0.030
-1.00%
Opening 11:31 04/07 EDT
OPEN
2.820
PREV CLOSE
2.990
HIGH
3.030
LOW
2.800
VOLUME
38.73K
TURNOVER
--
52 WEEK HIGH
9.96
52 WEEK LOW
2.790
MARKET CAP
31.92M
P/E (TTM)
-1.5330
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LTRN last week (0331-0404)?
Weekly Report · 4h ago
Lantern Pharma Price Target Announced at $25.00/Share by Lake Street
Dow Jones · 5d ago
Lake Street Initiates Coverage On Lantern Pharma with Buy Rating, Announces Price Target of $25
Benzinga · 5d ago
Lantern Pharma initiated with a Buy at Lake Street
TipRanks · 5d ago
Weekly Report: what happened at LTRN last week (0324-0328)?
Weekly Report · 03/31 11:43
Lantern Pharma’s Earnings Call: AI Advances Amid Financial Challenges
TipRanks · 03/29 00:02
Lantern Pharma Advances AI-Driven Oncology Pipeline
TipRanks · 03/28 03:53
Lantern Pharma outlines 2025 clinical milestones and key updates on oncology trials
Seeking Alpha · 03/28 00:36
More
About LTRN
More
Lantern Pharma Inc. is an artificial intelligence (AI) company. The Company is developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, leverages over 100 billion oncology-focused data points and a library of over 200+ advanced ML algorithms to help solve problems in oncology drug development. It is engaged in the development of its pipeline of therapies that span multiple cancer indications, including both solid tumors and blood cancers and an antibody drug conjugate (ADC) program. It has active clinical programs for its three lead small molecule drug candidates: LP-300, LP-184, and LP-284. These programs are focused on multiple cancer indications, including both solid tumors and blood cancers. It is also focused on the clinical execution of its therapies for CNS and brain cancers through Starlight Therapeutics Inc.
Recently
Symbol
Price
%Change

Webull offers Lantern Pharma Inc stock information, including NASDAQ: LTRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LTRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LTRN stock methods without spending real money on the virtual paper trading platform.